Home-Hero-4-no-button
Mobile-Hero-4-no-button

MERZ AESTHETICS ANNOUNCES THREE YEAR FDA CLEARANCE FOR CELLFINA® SYSTEM

RALEIGH, N.C. – OCTOBER 17, 2016 – Merz Aesthetics, a division of Merz North America (U.S. affiliate of the global Merz Pharma Group), announced today that the U.S. Food and Drug Administration (FDA) has cleared its Cellfina® System for the long-term improvement in the appearance of cellulite on the buttocks and thighs of adult females with no loss of benefit for up to 3 years.

 

View Press Release

MERZ ANNOUNCES CE CLEARANCE OF THE CELLFINA® SYSTEM  FOR THE LONG-TERM REDUCTION OF CELLULITE

FRANKFURT, GERMANY – JULY 14, 2016 – Merz Pharma Group today announced CE Mark clearance of the Cellfina® System, signifying its conformity with all EU regulations. Cellfina® is intended for long-term reduction of cellulite in the buttocks and thighs by precise release of targeted structural tissue (fibrous septae). Results of treatment with Cellfina® are expected to last up to two years. Cellfina® is currently available in the U.S. and has the longest duration of results as cleared by the U.S. Food and Drug Administration (FDA).

 

View Press Release